Low Venous Thromboembolic Risk With Bortezomib in Multiple Myeloma and Potential Protective Effect With Thalidomide/Lenalidomide-based Therapy: Review of Data From Phase 3 Trials and Studies of Novel Combination Regimens
Maurizio Zangari, Louis Fink, Fenghuang Zhan, Guido TricotVolume:
11
Year:
2011
Language:
english
DOI:
10.1016/j.clml.2011.03.006
File:
PDF, 868 KB
english, 2011